HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy - Wikidata - awgldk - TriplyDB

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

http://www.wikidata.org/entity/Q29616404

about

Modeling the within-host dynamics of HIV infection Transactivation of naturally occurring HIV-1 long terminal repeats by the JNK signaling pathway. The most frequent naturally occurring length polymorphism sequence introduces a novel binding site for AP-1 factors Trafficking of HIV-1 RNA is mediated by heterogeneous nuclear ribonucleoprotein A2 expression and impacts on viral assembly Efficient incorporation of HLA class II onto human immunodeficiency virus type 1 requires envelope glycoprotein packaging The frameshift signal of HIV-1 involves a potential intramolecular triplex RNA structure Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working Group.Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch Human herpesvirus 6 A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1 Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy Replicative homeostasis: a fundamental mechanism mediating selective viral replication and escape mutation Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3 A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS Could a simple surgical intervention eliminate HIV infection?Nucleotide modification at the gamma-phosphate leads to the improved fidelity of HIV-1 reverse transcriptase.dUTPase: the frequently overlooked enzyme encoded by many retroviruses Quantification of viral infection dynamics in animal experiments Structure-based methods for predicting target mutation-induced drug resistance and rational drug design to overcome the problem Current perspectives on HIV-1 antiretroviral drug resistance Evolutionary rescue: linking theory for conservation and medicine Viral quasispecies evolution HIV-1 reverse transcription Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations Unusual distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1 Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome Adherence and drug resistance: predictions for therapy outcome Cytopathic Mechanisms of HIV-1 Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease Structure of the Antiviral Assembly Inhibitor CAP-1 Complex with the HIV-1 CA Protein HIV-1 Protease Inhibitors from Inverse Design in the Substrate Envelope Exhibit Subnanomolar Binding to Drug-Resistant Variants Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design Structure of a G48H mutant of HIV-1 protease explains how glycine-48 replacements produce mutants resistant to inhibitor drugs Retroviral integration: Site matters: Mechanisms and consequences of retroviral integration site selection HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection Antiviral activity of CYC202 in HIV-1-infected cells

P2860

Q21245370-17D3ABD6-3F3E-41C2-BE64-DB6F78095D1E Q22253886-F1BD501E-6DBF-4518-B7A8-4F7FB2CBB6A9 Q24304953-9CCF2CEF-6364-4E9A-A10B-0DF80B43EECB Q24524821-016BFCCC-5FAE-42EC-85A5-DECEC987C432 Q24534107-A41A67D3-07EE-45E0-98A5-835396C7A326 Q24534187-7C5C8E97-CBDC-4DCF-8959-5F148FA65EBE Q24550959-83D6A38D-AEC0-4762-AFD1-0C27E2AF615A Q24651506-2237FCFF-7065-4BCB-B06B-642DE786B8CD Q24672335-0928C0AA-377B-4DAE-BF68-4CF89B27ABD1 Q24683663-CC82708D-68D3-4B90-868D-B117F0426806 Q24683706-4E48D758-E250-4054-815C-75DBDBF9DFCE Q24684152-762366CC-A34D-4BF1-A433-0B6F54B5B9C3 Q24798257-01EBCF4F-AE7A-466A-9C1B-EB22D0FD66D9 Q24801797-CF7D60B5-7329-4969-A5C2-B4C6530AC99E Q24803530-7B43BA3D-C95F-4103-8A2F-D282E0AD3B4F Q24805899-A7D8AE06-5A14-4438-B9A2-BB3137E5255D Q24817042-872A2FE6-67F1-45CB-B9F6-C8D65B195C5F Q26799724-F8737092-CB1B-42BE-9F6C-D1A137A464D4 Q26824804-968672CA-1193-4671-B414-B612E6979FA4 Q26829549-2B5F5F11-53DA-4FAD-88F0-8C58263C6B7F Q26852626-3C001BD1-C330-4B27-9847-EF8D49A0B076 Q26862297-1E743144-CF6F-4B56-8E71-7271D7BE64D7 Q27013917-9EE6E509-05E0-416F-AF7A-8C4365D3B5E6 Q27023387-C9521A6D-31F3-492E-8698-1B9080DAD951 Q27313556-E4E02106-F89E-4C77-A949-D9A050D7B514 Q27469554-22CB6723-9E5B-4465-B7A7-BDBC88EB4A74 Q27469694-6D22CEC5-9306-4FF6-A351-E3D0DFDF9F4D Q27471683-93CA9B38-CDDC-4BD5-99DF-60F4B234C589 Q27477742-EECC0B68-3CB4-49F3-8466-41EC8F9D616C Q27485043-7B7CDE41-E445-451A-9BA9-2170A834C2E7 Q27491275-C646F42F-FD70-4E61-B3CD-1A3A326179A1 Q27647665-90C00730-3552-4528-A3A8-075463FA3FC6 Q27647971-9AAD73C9-C549-48F3-A12F-B38123649471 Q27650325-E71B7CA6-EA77-4C41-9099-926BC1F5A0DD Q27651402-CD07A5A3-F625-4411-8C0B-0AAC7CC65966 Q27748828-73DC5FD9-BBB9-45AC-8842-E7731CAA1493 Q28088514-4E8E9160-539C-43DA-A0C1-DEE41D8EC30E Q28208528-9BF98A48-8A36-421F-BDE3-FA1766C84D18 Q28237240-9B0C2C63-F0A2-4613-8EDA-83DC1E48228F Q28292152-BDD02264-0B01-40A2-95E5-77CC0B728F35

P2860

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

http://www.wikidata.org/entity/Q29616404

description

1995 nî lūn-bûn

@nan

1995 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

HIV population dynamics in viv ...... ion, pathogenesis, and therapy

@ast

HIV population dynamics in viv ...... ion, pathogenesis, and therapy

@en

type

label

HIV population dynamics in viv ...... ion, pathogenesis, and therapy

@ast

HIV population dynamics in viv ...... ion, pathogenesis, and therapy

@en

prefLabel

HIV population dynamics in viv ...... ion, pathogenesis, and therapy

@ast

HIV population dynamics in viv ...... ion, pathogenesis, and therapy

@en

P1433

Q29616404-9EB10A4B-E000-4285-95AF-B23541E6CA1B

P1476

Q29616404-73D3E0C2-A664-4972-B0A8-28820678F1DA

P2093

Q29616404-FBB457C4-CD43-49B7-9B3B-7435BBDCC59F

P2860

Q29616404-0E327944-76FF-4C24-8131-4A55E60A5326

Q29616404-126CCEC5-077C-4B80-958E-DFB5FB0FB219

Q29616404-16E6E112-E21B-49B6-8442-37DC3F619106

Q29616404-1C3BBC7C-9DF7-4C6A-85D9-3FA7B23BAAB8

Q29616404-25E2A4E6-213F-4F9A-9443-AA0653103E79

Q29616404-33D30C30-D7FB-46DA-8C1E-1055BD3A7FA7

Q29616404-3E8D1771-C602-4246-9BE2-5B3BA46A6213

Q29616404-413B8589-CCBF-4FEB-B5E2-3C3ABB132E72

Q29616404-51AE92BD-4836-4A5B-8A72-72FEDD194194

Q29616404-7997A423-431D-4E51-AB78-B36FF10F0D3A

P304

Q29616404-8BE45FAD-7B40-440E-82D9-C2B11CB8D7E9

P31

Q29616404-16231453-F571-4254-8C8F-95B8BAF0525A

P3181

Q29616404-71114B5E-C0EC-4385-A302-4EDD40998F98

P356

Q29616404-13BBFCD2-7784-42F0-9970-6698DB8BE7A9

P407

Q29616404-013AAAEF-A6BF-4ADD-A47B-454D7C7AB005

P433

Q29616404-2A7E2284-F4A6-4174-BB41-C32B3EB24F21

P478

Q29616404-2B75AD20-8EBC-46DC-AC57-698F7D1213DB

P577

Q29616404-4B2D5053-85CE-41FB-A599-431A71C83E69

P5875

Q29616404-7E176D8E-2579-4972-B37B-DC618BC27825

P698

Q29616404-EB6BB466-7A41-4751-8777-819C02BEDA9B

P921

Q29616404-FC7B6929-8FA0-4C7D-B90F-7D1CB3992D74

P3181

P356

SCIENCE.7824947

P1433

P1476

HIV population dynamics in viv ...... ion, pathogenesis, and therapy

@en

P2093

Coffin JM

http://www.w3.org/2001/XMLSchema#string

P2860

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

Antigenic diversity thresholds and the development of AIDS

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations

Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions.

Molecular clock of viral evolution, and the neutral theory

The immunopathogenesis of human immunodeficiency virus infection.

Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1

P304

483-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

876252

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCIENCE.7824947

http://www.w3.org/2001/XMLSchema#string

P407

P433

5197

http://www.w3.org/2001/XMLSchema#string

P478

267

http://www.w3.org/2001/XMLSchema#string

P577

1995-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15374168

http://www.w3.org/2001/XMLSchema#string

P698

7824947

http://www.w3.org/2001/XMLSchema#string

P921